Recalls / Active ingredient / Linaclotide
Linaclotide
1 FDA drug recall involving the active ingredient “Linaclotide”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | Linzess (linaclotide) capsules 72 mcg/capsule 30 capsules Rx Only NDC 0456-1203-30 Distributed by: Allergan US | Cardinal Health Inc. |